Mounjaro dosage chart: the dose schedule on the FDA label
The Mounjaro label (revised 8/2026) gives a starting dose of 2.5 mg injected under the skin once weekly. If additional glycemic control is needed, the dose is increased in 2.5 mg increments after at least 4 weeks on the current dose. The maximum is 15 mg once weekly in adults and 10 mg once weekly in children aged 10 and older.
Starting dose, dose steps and maximum doses
From section 2.1 of the label, "Recommended Starting Dosage and Escalation". The label says to follow this schedule to reduce the risk of gastrointestinal adverse reactions.
| Step | Weekly dose | Label wording |
|---|---|---|
| Starting dose | 2.5 mg | The recommended starting dosage |
| Dose increases | In 2.5 mg increments | If additional glycemic control is needed, after at least 4 weeks on the current dose |
| Maximum in adults | 15 mg | The maximum dosage in adults |
| Maximum in children aged 10 and older | 10 mg | The maximum dosage in pediatric patients |
Pen, KwikPen and vial strengths
From section 3, "Dosage Forms and Strengths". Single-dose pens and vials hold one dose. Multi-dose vials and single-patient-use KwikPens hold 4 doses each: the vial column shows each dose volume with the total strength of the vial in brackets, and the KwikPen column the total strength of the pen.
| Dose | Single-dose pen or vial | Multi-dose vial | KwikPen |
|---|---|---|---|
| 2.5 mg | 2.5 mg/0.5 mL | 2.5 mg/0.6 mL (10 mg/2.4 mL) | 10 mg/2.4 mL |
| 5 mg | 5 mg/0.5 mL | 5 mg/0.6 mL (20 mg/2.4 mL) | 20 mg/2.4 mL |
| 7.5 mg | 7.5 mg/0.5 mL | 7.5 mg/0.6 mL (30 mg/2.4 mL) | 30 mg/2.4 mL |
| 10 mg | 10 mg/0.5 mL | 10 mg/0.6 mL (40 mg/2.4 mL) | 40 mg/2.4 mL |
| 12.5 mg | 12.5 mg/0.5 mL | 12.5 mg/0.6 mL (50 mg/2.4 mL) | 50 mg/2.4 mL |
| 15 mg | 15 mg/0.5 mL | 15 mg/0.6 mL (60 mg/2.4 mL) | 60 mg/2.4 mL |
Where this chart comes from
Every dose and strength above is copied from the US prescribing information for Mounjaro (tirzepatide) by Eli Lilly and Company: Mounjaro (tirzepatide) injection: prescribing information, Medication Guide and Instructions for Use, revised 8/2026 (DailyMed version 40, published 2 September 2026), sections 2 and 3. We read it on and update this page when the label changes.
Section 2 of the Mounjaro label also covers missed doses, changing the day of the week and administration for each presentation. Those instructions are not repeated here; read them in the label, the Medication Guide or the Instructions for Use for your pen or vial, or ask your pharmacist.
Compounded tirzepatide is not Mounjaro
Compounded tirzepatide is not Mounjaro. It is not FDA-approved, and this label and chart do not apply to it. If your prescription is a compounded vial, the tirzepatide calculator does the arithmetic from the amount your prescriber wrote to mL and syringe units, and the units to mg calculator works it the other way round. Check the result with your pharmacist.
Keeping a record of your dose steps
A log makes it easy to see which step of the schedule you are on and how you felt at each one. Record the dose your prescriber set, the date each new dose started, the strength printed on the pen or carton, and any side effects with their dates. The Mounjaro tracker page lists what to log for each Mounjaro injection, and how to track tirzepatide covers every tirzepatide brand. The GLP-1 tracker template is a free printable or CSV version.
PeptideMate keeps the same record on Android, iPhone, iPad and Mac, or in the browser with the free online peptide tracker. It records the dose you enter and never suggests one.
Mounjaro dosage chart questions
What is the starting dose on the Mounjaro label?
The label gives a recommended starting dosage of 2.5 mg injected subcutaneously once weekly. Your prescriber decides your dose.
What is the maximum Mounjaro dose on the label?
The label gives a maximum of 15 mg injected subcutaneously once weekly in adults and 10 mg once weekly in pediatric patients aged 10 and older.
Can I use this chart to change my dose?
No. It shows what the label prints, for reference. Your prescriber sets your dose and decides when it changes; ask them or your pharmacist about anything on this page.
Sources
- Mounjaro (tirzepatide) injection: prescribing information, Medication Guide and Instructions for Use, Eli Lilly and Company, via DailyMed (US National Library of Medicine); prescribing information revised 8/2026, DailyMed version 40 published 2 September 2026. Used for: Every dose and strength on this page: sections 2 (Dosage and Administration) and 3 (Dosage Forms and Strengths).
- FDA's concerns with unapproved GLP-1 drugs used for weight loss, US Food and Drug Administration. Used for: Compounded drugs are not FDA-approved.
Other label dosage charts
- Ozempic dosage chartStarting dose, dose steps, maintenance and maximum doses and pen strengths from the Ozempic label.
- Wegovy dosage chartWeekly injection steps, maintenance doses by use, daily tablet steps and strengths from the Wegovy label.
- Zepbound dosage chartStarting dose, 2.5 mg steps, maintenance and maximum doses and every pen, KwikPen and vial strength from the Zepbound label.
Reference only: this page reproduces the dose schedule on the FDA label and does not recommend Mounjaro, a dose or a schedule. See the medical disclaimer.